ArticleVaccines2023

Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19).

Hironori Nakagami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.